BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 20837891)

  • 21. [The implantable cardioverter-defibrillator: the Portuguese experience].
    Adragão P; Neves J; Sousa J; Fançoni J; da Silva N; Antunes E; Elvas L; Bernardo J
    Rev Port Cardiol; 1997 Apr; 16(4):367-74, 351-2. PubMed ID: 9254126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implantable cardioverter-defibrillators in patients with long QT syndrome: a multicentre study.
    Zienciuk-Krajka A; Sterliński M; Filipecki A; Owczuk R; Bednarek J; Kempa M; Sielski S; Dziduszko M; Mitkowski P; Kaźmierczak J; Kuśnierz J; Michałkiewicz D; Stec SM; Gułaj M; Majcherek R; Lubiński A; Raczak G
    Kardiol Pol; 2018; 76(12):1687-1696. PubMed ID: 30251242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
    Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
    Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do patients with long QT syndrome remain at risk for sudden cardiac death after 40 years of age?
    Postema PG; Wilde AA
    Nat Clin Pract Cardiovasc Med; 2008 Oct; 5(10):602-3. PubMed ID: 18665134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there a role for implantable cardioverter defibrillators in long QT syndrome?
    Welde AA
    J Cardiovasc Electrophysiol; 2002 Jan; 13(1 Suppl):S110-3. PubMed ID: 11852886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.
    Korte T; Köditz H; Niehaus M; Paul T; Tebbenjohanns J
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):924-32. PubMed ID: 15271011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients.
    Berul CI; Van Hare GF; Kertesz NJ; Dubin AM; Cecchin F; Collins KK; Cannon BC; Alexander ME; Triedman JK; Walsh EP; Friedman RA
    J Am Coll Cardiol; 2008 Apr; 51(17):1685-91. PubMed ID: 18436121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The use of implantable cardioverter-defibrillators (ICD) in children and adolescents].
    Apitz C; Gass M; Dörnberger V; Kuehlkamp V; Hofbeck M
    Klin Padiatr; 2006; 218(5):270-5. PubMed ID: 16947095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome by Sex in Patients With Long QT Syndrome With an Implantable Cardioverter Defibrillator.
    Younis A; Aktas MK; Rosero S; Kutyifa V; Polonsky B; McNitt S; Sotoodehnia N; Kudenchuk P; Rea TD; Arking DE; Goldenberg I; Zareba W
    J Am Heart Assoc; 2020 Oct; 9(19):e016398. PubMed ID: 33021160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of implantable cardioverter-defibrillator in inherited arrhythmogenic diseases: data from Italian ICD Registry for the years 2001-6.
    Proclemer A; Ghidina M; Facchin D; Rebellato L; Corrado D; Gasparini M; Gregori D
    Pacing Clin Electrophysiol; 2009 Apr; 32(4):434-45. PubMed ID: 19335851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of fatal arrhythmic events in long QT syndrome patients after syncope.
    Jons C; Moss AJ; Goldenberg I; Liu J; McNitt S; Zareba W; Qi M; Robinson JL
    J Am Coll Cardiol; 2010 Feb; 55(8):783-8. PubMed ID: 20170817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of Implantable Cardioverter-Defibrillators to Reduce Mortality in Patients With Long QT Syndrome.
    Wang M; Peterson DR; Rosero S; McNitt S; Rich DQ; Seplaki CL; Polonsky B; Goldenberg I; Zareba W
    J Am Coll Cardiol; 2021 Nov; 78(21):2076-2088. PubMed ID: 34794689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implantable cardioverter-defibrillator explantation for overdiagnosed or overtreated congenital long QT syndrome.
    Gaba P; Bos JM; Cannon BC; Cha YM; Friedman PA; Asirvatham SJ; Ackerman MJ
    Heart Rhythm; 2016 Apr; 13(4):879-85. PubMed ID: 26681611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of an implantable cardioverter-defibrillator in a neonate with LQT3 associated arrhythmias.
    Ten Harkel AD; Witsenburg M; de Jong PL; Jordaens L; Wijman M; Wilde AA
    Europace; 2005 Jan; 7(1):77-84. PubMed ID: 15670972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wearable cardioverter defibrillators for patients with long QT syndrome.
    Owen HJ; Bos JM; Ackerman MJ
    Int J Cardiol; 2018 Oct; 268():132-136. PubMed ID: 30041777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implantable cardioverter defibrillators and Chagas' disease: results of the ICD Registry Latin America.
    Muratore CA; Batista Sa LA; Chiale PA; Eloy R; Tentori MC; Escudero J; Lima AM; Medina LE; Garillo R; Maloney J
    Europace; 2009 Feb; 11(2):164-8. PubMed ID: 19056745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients.
    Wichter T; Paul M; Wollmann C; Acil T; Gerdes P; Ashraf O; Tjan TD; Soeparwata R; Block M; Borggrefe M; Scheld HH; Breithardt G; Böcker D
    Circulation; 2004 Mar; 109(12):1503-8. PubMed ID: 15007002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2.
    Sacher F; Probst V; Maury P; Babuty D; Mansourati J; Komatsu Y; Marquie C; Rosa A; Diallo A; Cassagneau R; Loizeau C; Martins R; Field ME; Derval N; Miyazaki S; Denis A; Nogami A; Ritter P; Gourraud JB; Ploux S; Rollin A; Zemmoura A; Lamaison D; Bordachar P; Pierre B; Jaïs P; Pasquié JL; Hocini M; Legal F; Defaye P; Boveda S; Iesaka Y; Mabo P; Haïssaguerre M
    Circulation; 2013 Oct; 128(16):1739-47. PubMed ID: 23995538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome after implantable cardioverter-defibrillator in patients with Brugada syndrome: the Gulf Brugada syndrome registry.
    Daoulah A; Alsheikh-Ali AA; Ocheltree AH; Ocheltree S; Al-Kaabi S; Malik M; Al-Habib AK; Hamed A; Al-Rawahi N; Al-Sayegh A; Al-Hasaniah S; Ul-Haq E
    J Electrocardiol; 2012; 45(3):327-32. PubMed ID: 22074744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.